NK Cell Expansion Kit
Background Information​
DSNK expansion kit can obtain more than 1 billion (1 x 10 ^ 9) NK cells in 2 weeks starting from 10 mL of blood. The NK cell purity ( CD3-CD56+%) is over 90% , and Cytotoxicity is about 80%.
Our DSNK does not require the purification and isolation of the NK cells from the blood prior to expansion. Additionally, it does not require feeder cells either. Importantly, DSNK can also be used for the NK cell expansion from cord blood. DSNK has received TFDA clearance as a Class I device in Taiwan.
​
Applications
Expand NK cells from peripheral blood / umbilical cord blood with high purity.
​
Competitive Advantages
-
No feeder cells required, no need to purify NK cells prior to expansion
-
NK cell amplifying fold > 3,000 folds
-
Purity of NK > 90 %
​
Product Details
-
Simple procedure, high expansion rate
-
TFDA medical device approval
-
Partner(s) currently conducting clinical study for TFDA approval for autologous NK Cell Therapy
Product Sheet